As someone who lost both of my wonderful parents to Cancer and consequently has been proud to support the development work in these sciences in Stevenage, I am today mindful of the developments of personalised vaccinations to cure this significant disease.

A company based in Hertfordshire has advised me that they now have the technology to resolve, 3 types of Cancer such as Colon, Lung and Skin Cancers with 4 personalised vaccinations provided per patient. The NHS-specific spending on cancer is estimated at around £14–15 billion annually, however Including broader economic and personal costs (lost productivity, caregiving, etc.), the total burden of preventable cancers to the state and society is in the £90–130 billion ballparks annually.

I am supporting a request from this company to government for a £15M grant in total over three years delivered monthly to bring this 4-injection based personalised vaccine treatment safely to market and we have the suitable production facilities already established and available at the Catapult facility in Stevenage.

Here are the very sad facts

Every minute of every day, there are 18 people dying from these Cancers globally, making a total of 1084 every hour and 26,000 people per day worldwide.

What do we need to resolve situations like this.

We need an early-stage investment scheme that takes opportunities like these with such a huge potential return in the national interest and mankind across the world to be provided with early financial support to further attract investment from the investment world. There is a suggestion that only 1 in 9 Angel Investments pay off and this is correct, which is why people and investment organisations steer clear of these unique opportunities in the first place, but areas that have the potential for such a significant impact on Government spending should be considered for some special assistance which can provide huge benefits to the future operational costs of the NHS and generate a valuable income for the UK economy.

Innovate U.K. exists to provide funding but sadly do not engage on a “non-disclose” basis which in some instances this means that inventors and scientists are not keen to share their specific details with them.

The Advanced Research and Invention Agency (ARIA) in the United Kingdom was officially established by an Act of Parliament—the Advanced Research and Invention Agency Act 2022, which received Royal Assent on 24 February 2022 and came into force in January 2023.

The Act was introduced in Parliament by the Secretary of State for Business, Energy and Industrial Strategy at the time, Kwasi Kwarteng, and the concept was notably championed behind the scenes by Dominic Cummings, a key adviser to then Prime Minister Boris Johnson

ARIA was provided the task to manage approximately £800 million over five years, and it was reported by the Financial Times that around half was still unallocated as of mid‑2025. However, sadly I understand that a technical research funding project does not exist in relation to Cancer prevention.

None of the above proposals should cost our government a single penny in real terms as they could all be constructed purely based on controlled funding release and eventual repayment but will provide stimulation and not contraction in the economy. Think in terms of a Student Loan arrangement with significant returns.

We have the capability, the knowledge, the equipment, the desire and the intention to save lives and we only need initial funding to get the concept safely tested and delivered.